Global Blood Purification Therapy Market Growth 2026-2032
The global Blood Purification Therapy market size is predicted to grow from US$ 21130 million in 2025 to US$ 31299 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.
Blood Purification refers to a group of extracorporeal therapies that remove uremic toxins, excess fluid, electrolytes, drugs and poisons, inflammatory mediators, bilirubin, pathogenic antibodies and other harmful blood components through diffusion, convection, adsorption, plasma separation and exchange, or combinations of these mechanisms, thereby replacing or supporting renal, hepatic, immune and metabolic functions. This catalog covers both equipment and core consumables used in hemodialysis, hemoperfusion, hemofiltration, continuous renal replacement therapy (CRRT), plasma exchange/plasma adsorption and other related blood-purification modalities. Equipment includes hemodialysis machines, blood-purification systems, CRRT systems, hemoperfusion machines, plasma-exchange systems and multi-therapy extracorporeal platforms, while core consumables include dialyzers, hemofilters, hemoperfusion cartridges/adsorption columns, plasma separators, CRRT filters and circuits, dialysis bloodlines, replacement fluids and other dialysis-related disposables. On a combined physical-unit basis for major equipment and core single-use consumables, global Blood Purification production reached approximately 1,350,000 K Units in 2025.
Growth in the end-stage kidney disease population remains the most stable source of demand for the global blood-purification market. Population aging and the increasing burden of diabetes and hypertension continue to expand the maintenance dialysis population while supporting broader use of high-flux dialysis, hemodiafiltration, adsorption-combination therapies and more biocompatible membrane technologies. Blood-purification equipment has a relatively long replacement cycle, whereas dialyzers, bloodlines, hemoperfusion cartridges, filters and dialysis concentrates are repeatedly consumed, making treatment frequency, disposable utilization and installed equipment base the core drivers of recurring industry revenue.
Acute kidney injury, sepsis, multiple-organ dysfunction, liver failure, poisoning and severe immune or metabolic disorders are extending blood purification beyond conventional renal replacement toward multi-organ support. The growing use of CRRT, hemoperfusion, plasma exchange, plasma adsorption and artificial-liver support in critical care is increasing requirements for precise fluid balance, stable continuous treatment and efficient removal of inflammatory mediators and protein-bound toxins. Equipment is evolving from single-modality systems toward multi-therapy platforms, while consumables are moving toward high-performance membranes, selective sorbents, lower albumin loss, improved anticoagulation compatibility and better biocompatibility, increasing the value content of the product mix.
China has become an important global manufacturing and demand center for blood-purification equipment and consumables, with domestic supply chains expanding rapidly in dialysis machines, dialyzers, hemoperfusion cartridges, tubing sets, CRRT circuits and adsorption materials. Volume-based procurement and reimbursement optimization improve treatment accessibility but also intensify price competition in mature disposable categories, encouraging manufacturers to differentiate through local membrane production, advanced sorbents, intelligent fluid management, connectivity and integrated equipment-consumables portfolios. At the same time, home dialysis, expansion of regional blood-purification centers, standardized critical-care treatment and international regulatory expansion create additional opportunities for manufacturers with strong production capabilities and quality systems.
This Insight Report provides a comprehensive analysis of the global Blood Purification Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Purification Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Purification Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Purification Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Purification Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Purification Therapy market by product type, application, key manufacturers and key regions and countries.
Blood Purification refers to a group of extracorporeal therapies that remove uremic toxins, excess fluid, electrolytes, drugs and poisons, inflammatory mediators, bilirubin, pathogenic antibodies and other harmful blood components through diffusion, convection, adsorption, plasma separation and exchange, or combinations of these mechanisms, thereby replacing or supporting renal, hepatic, immune and metabolic functions. This catalog covers both equipment and core consumables used in hemodialysis, hemoperfusion, hemofiltration, continuous renal replacement therapy (CRRT), plasma exchange/plasma adsorption and other related blood-purification modalities. Equipment includes hemodialysis machines, blood-purification systems, CRRT systems, hemoperfusion machines, plasma-exchange systems and multi-therapy extracorporeal platforms, while core consumables include dialyzers, hemofilters, hemoperfusion cartridges/adsorption columns, plasma separators, CRRT filters and circuits, dialysis bloodlines, replacement fluids and other dialysis-related disposables. On a combined physical-unit basis for major equipment and core single-use consumables, global Blood Purification production reached approximately 1,350,000 K Units in 2025.
Growth in the end-stage kidney disease population remains the most stable source of demand for the global blood-purification market. Population aging and the increasing burden of diabetes and hypertension continue to expand the maintenance dialysis population while supporting broader use of high-flux dialysis, hemodiafiltration, adsorption-combination therapies and more biocompatible membrane technologies. Blood-purification equipment has a relatively long replacement cycle, whereas dialyzers, bloodlines, hemoperfusion cartridges, filters and dialysis concentrates are repeatedly consumed, making treatment frequency, disposable utilization and installed equipment base the core drivers of recurring industry revenue.
Acute kidney injury, sepsis, multiple-organ dysfunction, liver failure, poisoning and severe immune or metabolic disorders are extending blood purification beyond conventional renal replacement toward multi-organ support. The growing use of CRRT, hemoperfusion, plasma exchange, plasma adsorption and artificial-liver support in critical care is increasing requirements for precise fluid balance, stable continuous treatment and efficient removal of inflammatory mediators and protein-bound toxins. Equipment is evolving from single-modality systems toward multi-therapy platforms, while consumables are moving toward high-performance membranes, selective sorbents, lower albumin loss, improved anticoagulation compatibility and better biocompatibility, increasing the value content of the product mix.
China has become an important global manufacturing and demand center for blood-purification equipment and consumables, with domestic supply chains expanding rapidly in dialysis machines, dialyzers, hemoperfusion cartridges, tubing sets, CRRT circuits and adsorption materials. Volume-based procurement and reimbursement optimization improve treatment accessibility but also intensify price competition in mature disposable categories, encouraging manufacturers to differentiate through local membrane production, advanced sorbents, intelligent fluid management, connectivity and integrated equipment-consumables portfolios. At the same time, home dialysis, expansion of regional blood-purification centers, standardized critical-care treatment and international regulatory expansion create additional opportunities for manufacturers with strong production capabilities and quality systems.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Blood Purification Therapy Industry Forecast” looks at past sales and reviews total world Blood Purification Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood Purification Therapy sales for 2026 through 2032. With Blood Purification Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Purification Therapy industry.This Insight Report provides a comprehensive analysis of the global Blood Purification Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Purification Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Purification Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Purification Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Purification Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Purification Therapy market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Hemodialysis
- Hemoperfusion
- Hemofiltration
- Continuous Renal Replacement Therapy
- Plasma Exchange And Plasma Adsorption
- Other
Segmentation by Product Form:
- Blood Purification Equipment
- Blood Purification Consumables
Segmentation by Care Setting:
- Hospitals
- Blood Purification Centers
- Home Care
- Other
Segmentation by Application:
- End-Stage Kidney Disease Requiring Long-Term Renal Replacement Therapy
- Acute Kidney Injury And Critical Care Blood Purification
- Liver Failure And Artificial Liver Support
- Poisoning Blood Purification
- Immune-Mediated Disease Blood Purification
- Metabolic Diseases and Special Component Removal
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chongqing Shanwaishan
- Weigao
- Sanxin Medtec
- Biolight
- Bain Medical
- Jafron Biomedical
- Peony Medical
- Guangzhou OCI Medical
- Koncen Biotech
- Ningbo Tianyi Medical
- Wellead Medical
- Shinva
- Chengdu Wesley
- Tuoren Medical
- Jiangxi Hongda
- Guanhuai Medical
- Guangzhou Jihua
- Kangbei Medical
- Foshan Biosun Medical
- Fresenius Medical Care
- Nikkiso
- B. Braun
- Vantive
- Asahi Kasei Medical
- Nipro
- Toray Medical
- Kaneka Medix
- CytoSorbents
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Blood Purification Therapy market?
- What factors are driving Blood Purification Therapy market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Blood Purification Therapy market opportunities vary by end market size?
- How does Blood Purification Therapy break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Purification Therapy Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Blood Purification Therapy by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Blood Purification Therapy by Country/Region, 2021, 2025 & 2032
2.2 Blood Purification Therapy Segment by Type
2.2.1 Hemodialysis
2.2.2 Hemoperfusion
2.2.3 Hemofiltration
2.2.4 Continuous Renal Replacement Therapy
2.2.5 Plasma Exchange And Plasma Adsorption
2.2.6 Other
2.2.7 Blood Purification Therapy Sales by Type
2.2.7.1 Global Blood Purification Therapy Sales Market Share by Type (2021-2026)
2.2.7.2 Global Blood Purification Therapy Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Blood Purification Therapy Sale Price by Type (2021-2026)
2.3 Blood Purification Therapy Segment by Product Form
2.3.1 Blood Purification Equipment
2.3.2 Blood Purification Consumables
2.3.3 Blood Purification Therapy Sales by Product Form
2.3.3.1 Global Blood Purification Therapy Sales Market Share by Product Form (2021-2026)
2.3.3.2 Global Blood Purification Therapy Revenue and Market Share by Product Form (2021-2026)
2.3.3.3 Global Blood Purification Therapy Sale Price by Product Form (2021-2026)
2.4 Blood Purification Therapy Segment by Care Setting
2.4.1 Hospitals
2.4.2 Blood Purification Centers
2.4.3 Home Care
2.4.4 Other
2.4.5 Blood Purification Therapy Sales by Care Setting
2.4.5.1 Global Blood Purification Therapy Sales Market Share by Care Setting (2021-2026)
2.4.5.2 Global Blood Purification Therapy Revenue and Market Share by Care Setting (2021-2026)
2.4.5.3 Global Blood Purification Therapy Sale Price by Care Setting (2021-2026)
2.5 Blood Purification Therapy Segment by Application
2.5.1 End-Stage Kidney Disease Requiring Long-Term Renal Replacement Therapy
2.5.2 Acute Kidney Injury And Critical Care Blood Purification
2.5.3 Liver Failure And Artificial Liver Support
2.5.4 Poisoning Blood Purification
2.5.5 Immune-Mediated Disease Blood Purification
2.5.6 Metabolic Diseases and Special Component Removal
2.5.7 Other
2.5.8 Blood Purification Therapy Sales by Application
2.5.8.1 Global Blood Purification Therapy Sale Market Share by Application (2021-2026)
2.5.8.2 Global Blood Purification Therapy Revenue and Market Share by Application (2021-2026)
2.5.8.3 Global Blood Purification Therapy Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Blood Purification Therapy Breakdown Data by Company
3.1.1 Global Blood Purification Therapy Annual Sales by Company (2021-2026)
3.1.2 Global Blood Purification Therapy Sales Market Share by Company (2021-2026)
3.2 Global Blood Purification Therapy Annual Revenue by Company (2021-2026)
3.2.1 Global Blood Purification Therapy Revenue by Company (2021-2026)
3.2.2 Global Blood Purification Therapy Revenue Market Share by Company (2021-2026)
3.3 Global Blood Purification Therapy Sale Price by Company
3.4 Key Manufacturers Blood Purification Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood Purification Therapy Product Location Distribution
3.4.2 Players Blood Purification Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BLOOD PURIFICATION THERAPY BY GEOGRAPHIC REGION
4.1 World Historic Blood Purification Therapy Market Size by Geographic Region (2021-2026)
4.1.1 Global Blood Purification Therapy Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Blood Purification Therapy Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Blood Purification Therapy Market Size by Country/Region (2021-2026)
4.2.1 Global Blood Purification Therapy Annual Sales by Country/Region (2021-2026)
4.2.2 Global Blood Purification Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Blood Purification Therapy Sales Growth
4.4 APAC Blood Purification Therapy Sales Growth
4.5 Europe Blood Purification Therapy Sales Growth
4.6 Middle East & Africa Blood Purification Therapy Sales Growth
5 AMERICAS
5.1 Americas Blood Purification Therapy Sales by Country
5.1.1 Americas Blood Purification Therapy Sales by Country (2021-2026)
5.1.2 Americas Blood Purification Therapy Revenue by Country (2021-2026)
5.2 Americas Blood Purification Therapy Sales by Type (2021-2026)
5.3 Americas Blood Purification Therapy Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Purification Therapy Sales by Region
6.1.1 APAC Blood Purification Therapy Sales by Region (2021-2026)
6.1.2 APAC Blood Purification Therapy Revenue by Region (2021-2026)
6.2 APAC Blood Purification Therapy Sales by Type (2021-2026)
6.3 APAC Blood Purification Therapy Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Blood Purification Therapy by Country
7.1.1 Europe Blood Purification Therapy Sales by Country (2021-2026)
7.1.2 Europe Blood Purification Therapy Revenue by Country (2021-2026)
7.2 Europe Blood Purification Therapy Sales by Type (2021-2026)
7.3 Europe Blood Purification Therapy Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Purification Therapy by Country
8.1.1 Middle East & Africa Blood Purification Therapy Sales by Country (2021-2026)
8.1.2 Middle East & Africa Blood Purification Therapy Revenue by Country (2021-2026)
8.2 Middle East & Africa Blood Purification Therapy Sales by Type (2021-2026)
8.3 Middle East & Africa Blood Purification Therapy Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Purification Therapy
10.3 Manufacturing Process Analysis of Blood Purification Therapy
10.4 Industry Chain Structure of Blood Purification Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood Purification Therapy Distributors
11.3 Blood Purification Therapy Customer
12 WORLD FORECAST REVIEW FOR BLOOD PURIFICATION THERAPY BY GEOGRAPHIC REGION
12.1 Global Blood Purification Therapy Market Size Forecast by Region
12.1.1 Global Blood Purification Therapy Forecast by Region (2027-2032)
12.1.2 Global Blood Purification Therapy Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Blood Purification Therapy Forecast by Type (2027-2032)
12.7 Global Blood Purification Therapy Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Chongqing Shanwaishan
13.1.1 Chongqing Shanwaishan Company Information
13.1.2 Chongqing Shanwaishan Blood Purification Therapy Product Portfolios and Specifications
13.1.3 Chongqing Shanwaishan Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Chongqing Shanwaishan Main Business Overview
13.1.5 Chongqing Shanwaishan Latest Developments
13.2 Weigao
13.2.1 Weigao Company Information
13.2.2 Weigao Blood Purification Therapy Product Portfolios and Specifications
13.2.3 Weigao Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Weigao Main Business Overview
13.2.5 Weigao Latest Developments
13.3 Sanxin Medtec
13.3.1 Sanxin Medtec Company Information
13.3.2 Sanxin Medtec Blood Purification Therapy Product Portfolios and Specifications
13.3.3 Sanxin Medtec Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sanxin Medtec Main Business Overview
13.3.5 Sanxin Medtec Latest Developments
13.4 Biolight
13.4.1 Biolight Company Information
13.4.2 Biolight Blood Purification Therapy Product Portfolios and Specifications
13.4.3 Biolight Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Biolight Main Business Overview
13.4.5 Biolight Latest Developments
13.5 Bain Medical
13.5.1 Bain Medical Company Information
13.5.2 Bain Medical Blood Purification Therapy Product Portfolios and Specifications
13.5.3 Bain Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Bain Medical Main Business Overview
13.5.5 Bain Medical Latest Developments
13.6 Jafron Biomedical
13.6.1 Jafron Biomedical Company Information
13.6.2 Jafron Biomedical Blood Purification Therapy Product Portfolios and Specifications
13.6.3 Jafron Biomedical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Jafron Biomedical Main Business Overview
13.6.5 Jafron Biomedical Latest Developments
13.7 Peony Medical
13.7.1 Peony Medical Company Information
13.7.2 Peony Medical Blood Purification Therapy Product Portfolios and Specifications
13.7.3 Peony Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Peony Medical Main Business Overview
13.7.5 Peony Medical Latest Developments
13.8 Guangzhou OCI Medical
13.8.1 Guangzhou OCI Medical Company Information
13.8.2 Guangzhou OCI Medical Blood Purification Therapy Product Portfolios and Specifications
13.8.3 Guangzhou OCI Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Guangzhou OCI Medical Main Business Overview
13.8.5 Guangzhou OCI Medical Latest Developments
13.9 Koncen Biotech
13.9.1 Koncen Biotech Company Information
13.9.2 Koncen Biotech Blood Purification Therapy Product Portfolios and Specifications
13.9.3 Koncen Biotech Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Koncen Biotech Main Business Overview
13.9.5 Koncen Biotech Latest Developments
13.10 Ningbo Tianyi Medical
13.10.1 Ningbo Tianyi Medical Company Information
13.10.2 Ningbo Tianyi Medical Blood Purification Therapy Product Portfolios and Specifications
13.10.3 Ningbo Tianyi Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Ningbo Tianyi Medical Main Business Overview
13.10.5 Ningbo Tianyi Medical Latest Developments
13.11 Wellead Medical
13.11.1 Wellead Medical Company Information
13.11.2 Wellead Medical Blood Purification Therapy Product Portfolios and Specifications
13.11.3 Wellead Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Wellead Medical Main Business Overview
13.11.5 Wellead Medical Latest Developments
13.12 Shinva
13.12.1 Shinva Company Information
13.12.2 Shinva Blood Purification Therapy Product Portfolios and Specifications
13.12.3 Shinva Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shinva Main Business Overview
13.12.5 Shinva Latest Developments
13.13 Chengdu Wesley
13.13.1 Chengdu Wesley Company Information
13.13.2 Chengdu Wesley Blood Purification Therapy Product Portfolios and Specifications
13.13.3 Chengdu Wesley Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Chengdu Wesley Main Business Overview
13.13.5 Chengdu Wesley Latest Developments
13.14 Tuoren Medical
13.14.1 Tuoren Medical Company Information
13.14.2 Tuoren Medical Blood Purification Therapy Product Portfolios and Specifications
13.14.3 Tuoren Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Tuoren Medical Main Business Overview
13.14.5 Tuoren Medical Latest Developments
13.15 Jiangxi Hongda
13.15.1 Jiangxi Hongda Company Information
13.15.2 Jiangxi Hongda Blood Purification Therapy Product Portfolios and Specifications
13.15.3 Jiangxi Hongda Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Jiangxi Hongda Main Business Overview
13.15.5 Jiangxi Hongda Latest Developments
13.16 Guanhuai Medical
13.16.1 Guanhuai Medical Company Information
13.16.2 Guanhuai Medical Blood Purification Therapy Product Portfolios and Specifications
13.16.3 Guanhuai Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Guanhuai Medical Main Business Overview
13.16.5 Guanhuai Medical Latest Developments
13.17 Guangzhou Jihua
13.17.1 Guangzhou Jihua Company Information
13.17.2 Guangzhou Jihua Blood Purification Therapy Product Portfolios and Specifications
13.17.3 Guangzhou Jihua Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Guangzhou Jihua Main Business Overview
13.17.5 Guangzhou Jihua Latest Developments
13.18 Kangbei Medical
13.18.1 Kangbei Medical Company Information
13.18.2 Kangbei Medical Blood Purification Therapy Product Portfolios and Specifications
13.18.3 Kangbei Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Kangbei Medical Main Business Overview
13.18.5 Kangbei Medical Latest Developments
13.19 Foshan Biosun Medical
13.19.1 Foshan Biosun Medical Company Information
13.19.2 Foshan Biosun Medical Blood Purification Therapy Product Portfolios and Specifications
13.19.3 Foshan Biosun Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Foshan Biosun Medical Main Business Overview
13.19.5 Foshan Biosun Medical Latest Developments
13.20 Fresenius Medical Care
13.20.1 Fresenius Medical Care Company Information
13.20.2 Fresenius Medical Care Blood Purification Therapy Product Portfolios and Specifications
13.20.3 Fresenius Medical Care Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Fresenius Medical Care Main Business Overview
13.20.5 Fresenius Medical Care Latest Developments
13.21 Nikkiso
13.21.1 Nikkiso Company Information
13.21.2 Nikkiso Blood Purification Therapy Product Portfolios and Specifications
13.21.3 Nikkiso Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Nikkiso Main Business Overview
13.21.5 Nikkiso Latest Developments
13.22 B. Braun
13.22.1 B. Braun Company Information
13.22.2 B. Braun Blood Purification Therapy Product Portfolios and Specifications
13.22.3 B. Braun Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 B. Braun Main Business Overview
13.22.5 B. Braun Latest Developments
13.23 Vantive
13.23.1 Vantive Company Information
13.23.2 Vantive Blood Purification Therapy Product Portfolios and Specifications
13.23.3 Vantive Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Vantive Main Business Overview
13.23.5 Vantive Latest Developments
13.24 Asahi Kasei Medical
13.24.1 Asahi Kasei Medical Company Information
13.24.2 Asahi Kasei Medical Blood Purification Therapy Product Portfolios and Specifications
13.24.3 Asahi Kasei Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Asahi Kasei Medical Main Business Overview
13.24.5 Asahi Kasei Medical Latest Developments
13.25 Nipro
13.25.1 Nipro Company Information
13.25.2 Nipro Blood Purification Therapy Product Portfolios and Specifications
13.25.3 Nipro Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Nipro Main Business Overview
13.25.5 Nipro Latest Developments
13.26 Toray Medical
13.26.1 Toray Medical Company Information
13.26.2 Toray Medical Blood Purification Therapy Product Portfolios and Specifications
13.26.3 Toray Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Toray Medical Main Business Overview
13.26.5 Toray Medical Latest Developments
13.27 Kaneka Medix
13.27.1 Kaneka Medix Company Information
13.27.2 Kaneka Medix Blood Purification Therapy Product Portfolios and Specifications
13.27.3 Kaneka Medix Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Kaneka Medix Main Business Overview
13.27.5 Kaneka Medix Latest Developments
13.28 CytoSorbents
13.28.1 CytoSorbents Company Information
13.28.2 CytoSorbents Blood Purification Therapy Product Portfolios and Specifications
13.28.3 CytoSorbents Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 CytoSorbents Main Business Overview
13.28.5 CytoSorbents Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Purification Therapy Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Blood Purification Therapy by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Blood Purification Therapy by Country/Region, 2021, 2025 & 2032
2.2 Blood Purification Therapy Segment by Type
2.2.1 Hemodialysis
2.2.2 Hemoperfusion
2.2.3 Hemofiltration
2.2.4 Continuous Renal Replacement Therapy
2.2.5 Plasma Exchange And Plasma Adsorption
2.2.6 Other
2.2.7 Blood Purification Therapy Sales by Type
2.2.7.1 Global Blood Purification Therapy Sales Market Share by Type (2021-2026)
2.2.7.2 Global Blood Purification Therapy Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Blood Purification Therapy Sale Price by Type (2021-2026)
2.3 Blood Purification Therapy Segment by Product Form
2.3.1 Blood Purification Equipment
2.3.2 Blood Purification Consumables
2.3.3 Blood Purification Therapy Sales by Product Form
2.3.3.1 Global Blood Purification Therapy Sales Market Share by Product Form (2021-2026)
2.3.3.2 Global Blood Purification Therapy Revenue and Market Share by Product Form (2021-2026)
2.3.3.3 Global Blood Purification Therapy Sale Price by Product Form (2021-2026)
2.4 Blood Purification Therapy Segment by Care Setting
2.4.1 Hospitals
2.4.2 Blood Purification Centers
2.4.3 Home Care
2.4.4 Other
2.4.5 Blood Purification Therapy Sales by Care Setting
2.4.5.1 Global Blood Purification Therapy Sales Market Share by Care Setting (2021-2026)
2.4.5.2 Global Blood Purification Therapy Revenue and Market Share by Care Setting (2021-2026)
2.4.5.3 Global Blood Purification Therapy Sale Price by Care Setting (2021-2026)
2.5 Blood Purification Therapy Segment by Application
2.5.1 End-Stage Kidney Disease Requiring Long-Term Renal Replacement Therapy
2.5.2 Acute Kidney Injury And Critical Care Blood Purification
2.5.3 Liver Failure And Artificial Liver Support
2.5.4 Poisoning Blood Purification
2.5.5 Immune-Mediated Disease Blood Purification
2.5.6 Metabolic Diseases and Special Component Removal
2.5.7 Other
2.5.8 Blood Purification Therapy Sales by Application
2.5.8.1 Global Blood Purification Therapy Sale Market Share by Application (2021-2026)
2.5.8.2 Global Blood Purification Therapy Revenue and Market Share by Application (2021-2026)
2.5.8.3 Global Blood Purification Therapy Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Blood Purification Therapy Breakdown Data by Company
3.1.1 Global Blood Purification Therapy Annual Sales by Company (2021-2026)
3.1.2 Global Blood Purification Therapy Sales Market Share by Company (2021-2026)
3.2 Global Blood Purification Therapy Annual Revenue by Company (2021-2026)
3.2.1 Global Blood Purification Therapy Revenue by Company (2021-2026)
3.2.2 Global Blood Purification Therapy Revenue Market Share by Company (2021-2026)
3.3 Global Blood Purification Therapy Sale Price by Company
3.4 Key Manufacturers Blood Purification Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood Purification Therapy Product Location Distribution
3.4.2 Players Blood Purification Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BLOOD PURIFICATION THERAPY BY GEOGRAPHIC REGION
4.1 World Historic Blood Purification Therapy Market Size by Geographic Region (2021-2026)
4.1.1 Global Blood Purification Therapy Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Blood Purification Therapy Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Blood Purification Therapy Market Size by Country/Region (2021-2026)
4.2.1 Global Blood Purification Therapy Annual Sales by Country/Region (2021-2026)
4.2.2 Global Blood Purification Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Blood Purification Therapy Sales Growth
4.4 APAC Blood Purification Therapy Sales Growth
4.5 Europe Blood Purification Therapy Sales Growth
4.6 Middle East & Africa Blood Purification Therapy Sales Growth
5 AMERICAS
5.1 Americas Blood Purification Therapy Sales by Country
5.1.1 Americas Blood Purification Therapy Sales by Country (2021-2026)
5.1.2 Americas Blood Purification Therapy Revenue by Country (2021-2026)
5.2 Americas Blood Purification Therapy Sales by Type (2021-2026)
5.3 Americas Blood Purification Therapy Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Purification Therapy Sales by Region
6.1.1 APAC Blood Purification Therapy Sales by Region (2021-2026)
6.1.2 APAC Blood Purification Therapy Revenue by Region (2021-2026)
6.2 APAC Blood Purification Therapy Sales by Type (2021-2026)
6.3 APAC Blood Purification Therapy Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Blood Purification Therapy by Country
7.1.1 Europe Blood Purification Therapy Sales by Country (2021-2026)
7.1.2 Europe Blood Purification Therapy Revenue by Country (2021-2026)
7.2 Europe Blood Purification Therapy Sales by Type (2021-2026)
7.3 Europe Blood Purification Therapy Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Purification Therapy by Country
8.1.1 Middle East & Africa Blood Purification Therapy Sales by Country (2021-2026)
8.1.2 Middle East & Africa Blood Purification Therapy Revenue by Country (2021-2026)
8.2 Middle East & Africa Blood Purification Therapy Sales by Type (2021-2026)
8.3 Middle East & Africa Blood Purification Therapy Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Purification Therapy
10.3 Manufacturing Process Analysis of Blood Purification Therapy
10.4 Industry Chain Structure of Blood Purification Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood Purification Therapy Distributors
11.3 Blood Purification Therapy Customer
12 WORLD FORECAST REVIEW FOR BLOOD PURIFICATION THERAPY BY GEOGRAPHIC REGION
12.1 Global Blood Purification Therapy Market Size Forecast by Region
12.1.1 Global Blood Purification Therapy Forecast by Region (2027-2032)
12.1.2 Global Blood Purification Therapy Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Blood Purification Therapy Forecast by Type (2027-2032)
12.7 Global Blood Purification Therapy Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Chongqing Shanwaishan
13.1.1 Chongqing Shanwaishan Company Information
13.1.2 Chongqing Shanwaishan Blood Purification Therapy Product Portfolios and Specifications
13.1.3 Chongqing Shanwaishan Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Chongqing Shanwaishan Main Business Overview
13.1.5 Chongqing Shanwaishan Latest Developments
13.2 Weigao
13.2.1 Weigao Company Information
13.2.2 Weigao Blood Purification Therapy Product Portfolios and Specifications
13.2.3 Weigao Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Weigao Main Business Overview
13.2.5 Weigao Latest Developments
13.3 Sanxin Medtec
13.3.1 Sanxin Medtec Company Information
13.3.2 Sanxin Medtec Blood Purification Therapy Product Portfolios and Specifications
13.3.3 Sanxin Medtec Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sanxin Medtec Main Business Overview
13.3.5 Sanxin Medtec Latest Developments
13.4 Biolight
13.4.1 Biolight Company Information
13.4.2 Biolight Blood Purification Therapy Product Portfolios and Specifications
13.4.3 Biolight Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Biolight Main Business Overview
13.4.5 Biolight Latest Developments
13.5 Bain Medical
13.5.1 Bain Medical Company Information
13.5.2 Bain Medical Blood Purification Therapy Product Portfolios and Specifications
13.5.3 Bain Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Bain Medical Main Business Overview
13.5.5 Bain Medical Latest Developments
13.6 Jafron Biomedical
13.6.1 Jafron Biomedical Company Information
13.6.2 Jafron Biomedical Blood Purification Therapy Product Portfolios and Specifications
13.6.3 Jafron Biomedical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Jafron Biomedical Main Business Overview
13.6.5 Jafron Biomedical Latest Developments
13.7 Peony Medical
13.7.1 Peony Medical Company Information
13.7.2 Peony Medical Blood Purification Therapy Product Portfolios and Specifications
13.7.3 Peony Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Peony Medical Main Business Overview
13.7.5 Peony Medical Latest Developments
13.8 Guangzhou OCI Medical
13.8.1 Guangzhou OCI Medical Company Information
13.8.2 Guangzhou OCI Medical Blood Purification Therapy Product Portfolios and Specifications
13.8.3 Guangzhou OCI Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Guangzhou OCI Medical Main Business Overview
13.8.5 Guangzhou OCI Medical Latest Developments
13.9 Koncen Biotech
13.9.1 Koncen Biotech Company Information
13.9.2 Koncen Biotech Blood Purification Therapy Product Portfolios and Specifications
13.9.3 Koncen Biotech Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Koncen Biotech Main Business Overview
13.9.5 Koncen Biotech Latest Developments
13.10 Ningbo Tianyi Medical
13.10.1 Ningbo Tianyi Medical Company Information
13.10.2 Ningbo Tianyi Medical Blood Purification Therapy Product Portfolios and Specifications
13.10.3 Ningbo Tianyi Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Ningbo Tianyi Medical Main Business Overview
13.10.5 Ningbo Tianyi Medical Latest Developments
13.11 Wellead Medical
13.11.1 Wellead Medical Company Information
13.11.2 Wellead Medical Blood Purification Therapy Product Portfolios and Specifications
13.11.3 Wellead Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Wellead Medical Main Business Overview
13.11.5 Wellead Medical Latest Developments
13.12 Shinva
13.12.1 Shinva Company Information
13.12.2 Shinva Blood Purification Therapy Product Portfolios and Specifications
13.12.3 Shinva Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shinva Main Business Overview
13.12.5 Shinva Latest Developments
13.13 Chengdu Wesley
13.13.1 Chengdu Wesley Company Information
13.13.2 Chengdu Wesley Blood Purification Therapy Product Portfolios and Specifications
13.13.3 Chengdu Wesley Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Chengdu Wesley Main Business Overview
13.13.5 Chengdu Wesley Latest Developments
13.14 Tuoren Medical
13.14.1 Tuoren Medical Company Information
13.14.2 Tuoren Medical Blood Purification Therapy Product Portfolios and Specifications
13.14.3 Tuoren Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Tuoren Medical Main Business Overview
13.14.5 Tuoren Medical Latest Developments
13.15 Jiangxi Hongda
13.15.1 Jiangxi Hongda Company Information
13.15.2 Jiangxi Hongda Blood Purification Therapy Product Portfolios and Specifications
13.15.3 Jiangxi Hongda Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Jiangxi Hongda Main Business Overview
13.15.5 Jiangxi Hongda Latest Developments
13.16 Guanhuai Medical
13.16.1 Guanhuai Medical Company Information
13.16.2 Guanhuai Medical Blood Purification Therapy Product Portfolios and Specifications
13.16.3 Guanhuai Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Guanhuai Medical Main Business Overview
13.16.5 Guanhuai Medical Latest Developments
13.17 Guangzhou Jihua
13.17.1 Guangzhou Jihua Company Information
13.17.2 Guangzhou Jihua Blood Purification Therapy Product Portfolios and Specifications
13.17.3 Guangzhou Jihua Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Guangzhou Jihua Main Business Overview
13.17.5 Guangzhou Jihua Latest Developments
13.18 Kangbei Medical
13.18.1 Kangbei Medical Company Information
13.18.2 Kangbei Medical Blood Purification Therapy Product Portfolios and Specifications
13.18.3 Kangbei Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Kangbei Medical Main Business Overview
13.18.5 Kangbei Medical Latest Developments
13.19 Foshan Biosun Medical
13.19.1 Foshan Biosun Medical Company Information
13.19.2 Foshan Biosun Medical Blood Purification Therapy Product Portfolios and Specifications
13.19.3 Foshan Biosun Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Foshan Biosun Medical Main Business Overview
13.19.5 Foshan Biosun Medical Latest Developments
13.20 Fresenius Medical Care
13.20.1 Fresenius Medical Care Company Information
13.20.2 Fresenius Medical Care Blood Purification Therapy Product Portfolios and Specifications
13.20.3 Fresenius Medical Care Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Fresenius Medical Care Main Business Overview
13.20.5 Fresenius Medical Care Latest Developments
13.21 Nikkiso
13.21.1 Nikkiso Company Information
13.21.2 Nikkiso Blood Purification Therapy Product Portfolios and Specifications
13.21.3 Nikkiso Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Nikkiso Main Business Overview
13.21.5 Nikkiso Latest Developments
13.22 B. Braun
13.22.1 B. Braun Company Information
13.22.2 B. Braun Blood Purification Therapy Product Portfolios and Specifications
13.22.3 B. Braun Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 B. Braun Main Business Overview
13.22.5 B. Braun Latest Developments
13.23 Vantive
13.23.1 Vantive Company Information
13.23.2 Vantive Blood Purification Therapy Product Portfolios and Specifications
13.23.3 Vantive Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Vantive Main Business Overview
13.23.5 Vantive Latest Developments
13.24 Asahi Kasei Medical
13.24.1 Asahi Kasei Medical Company Information
13.24.2 Asahi Kasei Medical Blood Purification Therapy Product Portfolios and Specifications
13.24.3 Asahi Kasei Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Asahi Kasei Medical Main Business Overview
13.24.5 Asahi Kasei Medical Latest Developments
13.25 Nipro
13.25.1 Nipro Company Information
13.25.2 Nipro Blood Purification Therapy Product Portfolios and Specifications
13.25.3 Nipro Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Nipro Main Business Overview
13.25.5 Nipro Latest Developments
13.26 Toray Medical
13.26.1 Toray Medical Company Information
13.26.2 Toray Medical Blood Purification Therapy Product Portfolios and Specifications
13.26.3 Toray Medical Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Toray Medical Main Business Overview
13.26.5 Toray Medical Latest Developments
13.27 Kaneka Medix
13.27.1 Kaneka Medix Company Information
13.27.2 Kaneka Medix Blood Purification Therapy Product Portfolios and Specifications
13.27.3 Kaneka Medix Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Kaneka Medix Main Business Overview
13.27.5 Kaneka Medix Latest Developments
13.28 CytoSorbents
13.28.1 CytoSorbents Company Information
13.28.2 CytoSorbents Blood Purification Therapy Product Portfolios and Specifications
13.28.3 CytoSorbents Blood Purification Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 CytoSorbents Main Business Overview
13.28.5 CytoSorbents Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Blood Purification Therapy Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Blood Purification Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Hemodialysis
Table 4. Major Players of Hemoperfusion
Table 5. Major Players of Hemofiltration
Table 6. Major Players of Continuous Renal Replacement Therapy
Table 7. Major Players of Plasma Exchange And Plasma Adsorption
Table 8. Major Players of Other
Table 9. Global Blood Purification Therapy Sales by Type (2021-2026) & (K Units)
Table 10. Global Blood Purification Therapy Sales Market Share by Type (2021-2026)
Table 11. Global Blood Purification Therapy Revenue by Type (2021-2026) & ($ million)
Table 12. Global Blood Purification Therapy Revenue Market Share by Type (2021-2026)
Table 13. Global Blood Purification Therapy Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Major Players of Blood Purification Equipment
Table 15. Major Players of Blood Purification Consumables
Table 16. Global Blood Purification Therapy Sales by Product Form (2021-2026) & (K Units)
Table 17. Global Blood Purification Therapy Sales Market Share by Product Form (2021-2026)
Table 18. Global Blood Purification Therapy Revenue by Product Form (2021-2026) & ($ million)
Table 19. Global Blood Purification Therapy Revenue Market Share by Product Form (2021-2026)
Table 20. Global Blood Purification Therapy Sale Price by Product Form (2021-2026) & (US$/Unit)
Table 21. Major Players of Hospitals
Table 22. Major Players of Blood Purification Centers
Table 23. Major Players of Home Care
Table 24. Major Players of Other
Table 25. Global Blood Purification Therapy Sales by Care Setting (2021-2026) & (K Units)
Table 26. Global Blood Purification Therapy Sales Market Share by Care Setting (2021-2026)
Table 27. Global Blood Purification Therapy Revenue by Care Setting (2021-2026) & ($ million)
Table 28. Global Blood Purification Therapy Revenue Market Share by Care Setting (2021-2026)
Table 29. Global Blood Purification Therapy Sale Price by Care Setting (2021-2026) & (US$/Unit)
Table 30. Global Blood Purification Therapy Sale by Application (2021-2026) & (K Units)
Table 31. Global Blood Purification Therapy Sale Market Share by Application (2021-2026)
Table 32. Global Blood Purification Therapy Revenue by Application (2021-2026) & ($ million)
Table 33. Global Blood Purification Therapy Revenue Market Share by Application (2021-2026)
Table 34. Global Blood Purification Therapy Sale Price by Application (2021-2026) & (US$/Unit)
Table 35. Global Blood Purification Therapy Sales by Company (2021-2026) & (K Units)
Table 36. Global Blood Purification Therapy Sales Market Share by Company (2021-2026)
Table 37. Global Blood Purification Therapy Revenue by Company (2021-2026) & ($ millions)
Table 38. Global Blood Purification Therapy Revenue Market Share by Company (2021-2026)
Table 39. Global Blood Purification Therapy Sale Price by Company (2021-2026) & (US$/Unit)
Table 40. Key Manufacturers Blood Purification Therapy Producing Area Distribution and Sales Area
Table 41. Players Blood Purification Therapy Products Offered
Table 42. Blood Purification Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 43. New Products and Potential Entrants
Table 44. Market M&A Activity & Strategy
Table 45. Global Blood Purification Therapy Sales by Geographic Region (2021-2026) & (K Units)
Table 46. Global Blood Purification Therapy Sales Market Share Geographic Region (2021-2026)
Table 47. Global Blood Purification Therapy Revenue by Geographic Region (2021-2026) & ($ millions)
Table 48. Global Blood Purification Therapy Revenue Market Share by Geographic Region (2021-2026)
Table 49. Global Blood Purification Therapy Sales by Country/Region (2021-2026) & (K Units)
Table 50. Global Blood Purification Therapy Sales Market Share by Country/Region (2021-2026)
Table 51. Global Blood Purification Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 52. Global Blood Purification Therapy Revenue Market Share by Country/Region (2021-2026)
Table 53. Americas Blood Purification Therapy Sales by Country (2021-2026) & (K Units)
Table 54. Americas Blood Purification Therapy Sales Market Share by Country (2021-2026)
Table 55. Americas Blood Purification Therapy Revenue by Country (2021-2026) & ($ millions)
Table 56. Americas Blood Purification Therapy Sales by Type (2021-2026) & (K Units)
Table 57. Americas Blood Purification Therapy Sales by Application (2021-2026) & (K Units)
Table 58. APAC Blood Purification Therapy Sales by Region (2021-2026) & (K Units)
Table 59. APAC Blood Purification Therapy Sales Market Share by Region (2021-2026)
Table 60. APAC Blood Purification Therapy Revenue by Region (2021-2026) & ($ millions)
Table 61. APAC Blood Purification Therapy Sales by Type (2021-2026) & (K Units)
Table 62. APAC Blood Purification Therapy Sales by Application (2021-2026) & (K Units)
Table 63. Europe Blood Purification Therapy Sales by Country (2021-2026) & (K Units)
Table 64. Europe Blood Purification Therapy Revenue by Country (2021-2026) & ($ millions)
Table 65. Europe Blood Purification Therapy Sales by Type (2021-2026) & (K Units)
Table 66. Europe Blood Purification Therapy Sales by Application (2021-2026) & (K Units)
Table 67. Middle East & Africa Blood Purification Therapy Sales by Country (2021-2026) & (K Units)
Table 68. Middle East & Africa Blood Purification Therapy Revenue Market Share by Country (2021-2026)
Table 69. Middle East & Africa Blood Purification Therapy Sales by Type (2021-2026) & (K Units)
Table 70. Middle East & Africa Blood Purification Therapy Sales by Application (2021-2026) & (K Units)
Table 71. Key Market Drivers & Growth Opportunities of Blood Purification Therapy
Table 72. Key Market Challenges & Risks of Blood Purification Therapy
Table 73. Key Industry Trends of Blood Purification Therapy
Table 74. Blood Purification Therapy Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Blood Purification Therapy Distributors List
Table 77. Blood Purification Therapy Customer List
Table 78. Global Blood Purification Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 79. Global Blood Purification Therapy Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Americas Blood Purification Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Americas Blood Purification Therapy Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. APAC Blood Purification Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 83. APAC Blood Purification Therapy Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Europe Blood Purification Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Europe Blood Purification Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Middle East & Africa Blood Purification Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 87. Middle East & Africa Blood Purification Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Global Blood Purification Therapy Sales Forecast by Type (2027-2032) & (K Units)
Table 89. Global Blood Purification Therapy Revenue Forecast by Type (2027-2032) & ($ millions)
Table 90. Global Blood Purification Therapy Sales Forecast by Application (2027-2032) & (K Units)
Table 91. Global Blood Purification Therapy Revenue Forecast by Application (2027-2032) & ($ millions)
Table 92. Chongqing Shanwaishan Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 93. Chongqing Shanwaishan Blood Purification Therapy Product Portfolios and Specifications
Table 94. Chongqing Shanwaishan Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Chongqing Shanwaishan Main Business
Table 96. Chongqing Shanwaishan Latest Developments
Table 97. Weigao Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 98. Weigao Blood Purification Therapy Product Portfolios and Specifications
Table 99. Weigao Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Weigao Main Business
Table 101. Weigao Latest Developments
Table 102. Sanxin Medtec Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanxin Medtec Blood Purification Therapy Product Portfolios and Specifications
Table 104. Sanxin Medtec Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Sanxin Medtec Main Business
Table 106. Sanxin Medtec Latest Developments
Table 107. Biolight Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 108. Biolight Blood Purification Therapy Product Portfolios and Specifications
Table 109. Biolight Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Biolight Main Business
Table 111. Biolight Latest Developments
Table 112. Bain Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 113. Bain Medical Blood Purification Therapy Product Portfolios and Specifications
Table 114. Bain Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Bain Medical Main Business
Table 116. Bain Medical Latest Developments
Table 117. Jafron Biomedical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 118. Jafron Biomedical Blood Purification Therapy Product Portfolios and Specifications
Table 119. Jafron Biomedical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Jafron Biomedical Main Business
Table 121. Jafron Biomedical Latest Developments
Table 122. Peony Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 123. Peony Medical Blood Purification Therapy Product Portfolios and Specifications
Table 124. Peony Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Peony Medical Main Business
Table 126. Peony Medical Latest Developments
Table 127. Guangzhou OCI Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 128. Guangzhou OCI Medical Blood Purification Therapy Product Portfolios and Specifications
Table 129. Guangzhou OCI Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Guangzhou OCI Medical Main Business
Table 131. Guangzhou OCI Medical Latest Developments
Table 132. Koncen Biotech Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 133. Koncen Biotech Blood Purification Therapy Product Portfolios and Specifications
Table 134. Koncen Biotech Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Koncen Biotech Main Business
Table 136. Koncen Biotech Latest Developments
Table 137. Ningbo Tianyi Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 138. Ningbo Tianyi Medical Blood Purification Therapy Product Portfolios and Specifications
Table 139. Ningbo Tianyi Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Ningbo Tianyi Medical Main Business
Table 141. Ningbo Tianyi Medical Latest Developments
Table 142. Wellead Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 143. Wellead Medical Blood Purification Therapy Product Portfolios and Specifications
Table 144. Wellead Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Wellead Medical Main Business
Table 146. Wellead Medical Latest Developments
Table 147. Shinva Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 148. Shinva Blood Purification Therapy Product Portfolios and Specifications
Table 149. Shinva Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Shinva Main Business
Table 151. Shinva Latest Developments
Table 152. Chengdu Wesley Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 153. Chengdu Wesley Blood Purification Therapy Product Portfolios and Specifications
Table 154. Chengdu Wesley Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Chengdu Wesley Main Business
Table 156. Chengdu Wesley Latest Developments
Table 157. Tuoren Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 158. Tuoren Medical Blood Purification Therapy Product Portfolios and Specifications
Table 159. Tuoren Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Tuoren Medical Main Business
Table 161. Tuoren Medical Latest Developments
Table 162. Jiangxi Hongda Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 163. Jiangxi Hongda Blood Purification Therapy Product Portfolios and Specifications
Table 164. Jiangxi Hongda Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Jiangxi Hongda Main Business
Table 166. Jiangxi Hongda Latest Developments
Table 167. Guanhuai Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 168. Guanhuai Medical Blood Purification Therapy Product Portfolios and Specifications
Table 169. Guanhuai Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Guanhuai Medical Main Business
Table 171. Guanhuai Medical Latest Developments
Table 172. Guangzhou Jihua Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 173. Guangzhou Jihua Blood Purification Therapy Product Portfolios and Specifications
Table 174. Guangzhou Jihua Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 175. Guangzhou Jihua Main Business
Table 176. Guangzhou Jihua Latest Developments
Table 177. Kangbei Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 178. Kangbei Medical Blood Purification Therapy Product Portfolios and Specifications
Table 179. Kangbei Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 180. Kangbei Medical Main Business
Table 181. Kangbei Medical Latest Developments
Table 182. Foshan Biosun Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 183. Foshan Biosun Medical Blood Purification Therapy Product Portfolios and Specifications
Table 184. Foshan Biosun Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 185. Foshan Biosun Medical Main Business
Table 186. Foshan Biosun Medical Latest Developments
Table 187. Fresenius Medical Care Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 188. Fresenius Medical Care Blood Purification Therapy Product Portfolios and Specifications
Table 189. Fresenius Medical Care Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 190. Fresenius Medical Care Main Business
Table 191. Fresenius Medical Care Latest Developments
Table 192. Nikkiso Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 193. Nikkiso Blood Purification Therapy Product Portfolios and Specifications
Table 194. Nikkiso Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 195. Nikkiso Main Business
Table 196. Nikkiso Latest Developments
Table 197. B. Braun Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 198. B. Braun Blood Purification Therapy Product Portfolios and Specifications
Table 199. B. Braun Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 200. B. Braun Main Business
Table 201. B. Braun Latest Developments
Table 202. Vantive Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 203. Vantive Blood Purification Therapy Product Portfolios and Specifications
Table 204. Vantive Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 205. Vantive Main Business
Table 206. Vantive Latest Developments
Table 207. Asahi Kasei Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 208. Asahi Kasei Medical Blood Purification Therapy Product Portfolios and Specifications
Table 209. Asahi Kasei Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 210. Asahi Kasei Medical Main Business
Table 211. Asahi Kasei Medical Latest Developments
Table 212. Nipro Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 213. Nipro Blood Purification Therapy Product Portfolios and Specifications
Table 214. Nipro Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 215. Nipro Main Business
Table 216. Nipro Latest Developments
Table 217. Toray Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 218. Toray Medical Blood Purification Therapy Product Portfolios and Specifications
Table 219. Toray Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 220. Toray Medical Main Business
Table 221. Toray Medical Latest Developments
Table 222. Kaneka Medix Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 223. Kaneka Medix Blood Purification Therapy Product Portfolios and Specifications
Table 224. Kaneka Medix Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 225. Kaneka Medix Main Business
Table 226. Kaneka Medix Latest Developments
Table 227. CytoSorbents Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 228. CytoSorbents Blood Purification Therapy Product Portfolios and Specifications
Table 229. CytoSorbents Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 230. CytoSorbents Main Business
Table 231. CytoSorbents Latest Developments
Table 1. Blood Purification Therapy Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Blood Purification Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Hemodialysis
Table 4. Major Players of Hemoperfusion
Table 5. Major Players of Hemofiltration
Table 6. Major Players of Continuous Renal Replacement Therapy
Table 7. Major Players of Plasma Exchange And Plasma Adsorption
Table 8. Major Players of Other
Table 9. Global Blood Purification Therapy Sales by Type (2021-2026) & (K Units)
Table 10. Global Blood Purification Therapy Sales Market Share by Type (2021-2026)
Table 11. Global Blood Purification Therapy Revenue by Type (2021-2026) & ($ million)
Table 12. Global Blood Purification Therapy Revenue Market Share by Type (2021-2026)
Table 13. Global Blood Purification Therapy Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Major Players of Blood Purification Equipment
Table 15. Major Players of Blood Purification Consumables
Table 16. Global Blood Purification Therapy Sales by Product Form (2021-2026) & (K Units)
Table 17. Global Blood Purification Therapy Sales Market Share by Product Form (2021-2026)
Table 18. Global Blood Purification Therapy Revenue by Product Form (2021-2026) & ($ million)
Table 19. Global Blood Purification Therapy Revenue Market Share by Product Form (2021-2026)
Table 20. Global Blood Purification Therapy Sale Price by Product Form (2021-2026) & (US$/Unit)
Table 21. Major Players of Hospitals
Table 22. Major Players of Blood Purification Centers
Table 23. Major Players of Home Care
Table 24. Major Players of Other
Table 25. Global Blood Purification Therapy Sales by Care Setting (2021-2026) & (K Units)
Table 26. Global Blood Purification Therapy Sales Market Share by Care Setting (2021-2026)
Table 27. Global Blood Purification Therapy Revenue by Care Setting (2021-2026) & ($ million)
Table 28. Global Blood Purification Therapy Revenue Market Share by Care Setting (2021-2026)
Table 29. Global Blood Purification Therapy Sale Price by Care Setting (2021-2026) & (US$/Unit)
Table 30. Global Blood Purification Therapy Sale by Application (2021-2026) & (K Units)
Table 31. Global Blood Purification Therapy Sale Market Share by Application (2021-2026)
Table 32. Global Blood Purification Therapy Revenue by Application (2021-2026) & ($ million)
Table 33. Global Blood Purification Therapy Revenue Market Share by Application (2021-2026)
Table 34. Global Blood Purification Therapy Sale Price by Application (2021-2026) & (US$/Unit)
Table 35. Global Blood Purification Therapy Sales by Company (2021-2026) & (K Units)
Table 36. Global Blood Purification Therapy Sales Market Share by Company (2021-2026)
Table 37. Global Blood Purification Therapy Revenue by Company (2021-2026) & ($ millions)
Table 38. Global Blood Purification Therapy Revenue Market Share by Company (2021-2026)
Table 39. Global Blood Purification Therapy Sale Price by Company (2021-2026) & (US$/Unit)
Table 40. Key Manufacturers Blood Purification Therapy Producing Area Distribution and Sales Area
Table 41. Players Blood Purification Therapy Products Offered
Table 42. Blood Purification Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 43. New Products and Potential Entrants
Table 44. Market M&A Activity & Strategy
Table 45. Global Blood Purification Therapy Sales by Geographic Region (2021-2026) & (K Units)
Table 46. Global Blood Purification Therapy Sales Market Share Geographic Region (2021-2026)
Table 47. Global Blood Purification Therapy Revenue by Geographic Region (2021-2026) & ($ millions)
Table 48. Global Blood Purification Therapy Revenue Market Share by Geographic Region (2021-2026)
Table 49. Global Blood Purification Therapy Sales by Country/Region (2021-2026) & (K Units)
Table 50. Global Blood Purification Therapy Sales Market Share by Country/Region (2021-2026)
Table 51. Global Blood Purification Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 52. Global Blood Purification Therapy Revenue Market Share by Country/Region (2021-2026)
Table 53. Americas Blood Purification Therapy Sales by Country (2021-2026) & (K Units)
Table 54. Americas Blood Purification Therapy Sales Market Share by Country (2021-2026)
Table 55. Americas Blood Purification Therapy Revenue by Country (2021-2026) & ($ millions)
Table 56. Americas Blood Purification Therapy Sales by Type (2021-2026) & (K Units)
Table 57. Americas Blood Purification Therapy Sales by Application (2021-2026) & (K Units)
Table 58. APAC Blood Purification Therapy Sales by Region (2021-2026) & (K Units)
Table 59. APAC Blood Purification Therapy Sales Market Share by Region (2021-2026)
Table 60. APAC Blood Purification Therapy Revenue by Region (2021-2026) & ($ millions)
Table 61. APAC Blood Purification Therapy Sales by Type (2021-2026) & (K Units)
Table 62. APAC Blood Purification Therapy Sales by Application (2021-2026) & (K Units)
Table 63. Europe Blood Purification Therapy Sales by Country (2021-2026) & (K Units)
Table 64. Europe Blood Purification Therapy Revenue by Country (2021-2026) & ($ millions)
Table 65. Europe Blood Purification Therapy Sales by Type (2021-2026) & (K Units)
Table 66. Europe Blood Purification Therapy Sales by Application (2021-2026) & (K Units)
Table 67. Middle East & Africa Blood Purification Therapy Sales by Country (2021-2026) & (K Units)
Table 68. Middle East & Africa Blood Purification Therapy Revenue Market Share by Country (2021-2026)
Table 69. Middle East & Africa Blood Purification Therapy Sales by Type (2021-2026) & (K Units)
Table 70. Middle East & Africa Blood Purification Therapy Sales by Application (2021-2026) & (K Units)
Table 71. Key Market Drivers & Growth Opportunities of Blood Purification Therapy
Table 72. Key Market Challenges & Risks of Blood Purification Therapy
Table 73. Key Industry Trends of Blood Purification Therapy
Table 74. Blood Purification Therapy Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Blood Purification Therapy Distributors List
Table 77. Blood Purification Therapy Customer List
Table 78. Global Blood Purification Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 79. Global Blood Purification Therapy Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Americas Blood Purification Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Americas Blood Purification Therapy Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. APAC Blood Purification Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 83. APAC Blood Purification Therapy Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Europe Blood Purification Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Europe Blood Purification Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Middle East & Africa Blood Purification Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 87. Middle East & Africa Blood Purification Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Global Blood Purification Therapy Sales Forecast by Type (2027-2032) & (K Units)
Table 89. Global Blood Purification Therapy Revenue Forecast by Type (2027-2032) & ($ millions)
Table 90. Global Blood Purification Therapy Sales Forecast by Application (2027-2032) & (K Units)
Table 91. Global Blood Purification Therapy Revenue Forecast by Application (2027-2032) & ($ millions)
Table 92. Chongqing Shanwaishan Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 93. Chongqing Shanwaishan Blood Purification Therapy Product Portfolios and Specifications
Table 94. Chongqing Shanwaishan Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Chongqing Shanwaishan Main Business
Table 96. Chongqing Shanwaishan Latest Developments
Table 97. Weigao Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 98. Weigao Blood Purification Therapy Product Portfolios and Specifications
Table 99. Weigao Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Weigao Main Business
Table 101. Weigao Latest Developments
Table 102. Sanxin Medtec Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanxin Medtec Blood Purification Therapy Product Portfolios and Specifications
Table 104. Sanxin Medtec Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Sanxin Medtec Main Business
Table 106. Sanxin Medtec Latest Developments
Table 107. Biolight Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 108. Biolight Blood Purification Therapy Product Portfolios and Specifications
Table 109. Biolight Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Biolight Main Business
Table 111. Biolight Latest Developments
Table 112. Bain Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 113. Bain Medical Blood Purification Therapy Product Portfolios and Specifications
Table 114. Bain Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Bain Medical Main Business
Table 116. Bain Medical Latest Developments
Table 117. Jafron Biomedical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 118. Jafron Biomedical Blood Purification Therapy Product Portfolios and Specifications
Table 119. Jafron Biomedical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Jafron Biomedical Main Business
Table 121. Jafron Biomedical Latest Developments
Table 122. Peony Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 123. Peony Medical Blood Purification Therapy Product Portfolios and Specifications
Table 124. Peony Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Peony Medical Main Business
Table 126. Peony Medical Latest Developments
Table 127. Guangzhou OCI Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 128. Guangzhou OCI Medical Blood Purification Therapy Product Portfolios and Specifications
Table 129. Guangzhou OCI Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Guangzhou OCI Medical Main Business
Table 131. Guangzhou OCI Medical Latest Developments
Table 132. Koncen Biotech Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 133. Koncen Biotech Blood Purification Therapy Product Portfolios and Specifications
Table 134. Koncen Biotech Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Koncen Biotech Main Business
Table 136. Koncen Biotech Latest Developments
Table 137. Ningbo Tianyi Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 138. Ningbo Tianyi Medical Blood Purification Therapy Product Portfolios and Specifications
Table 139. Ningbo Tianyi Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Ningbo Tianyi Medical Main Business
Table 141. Ningbo Tianyi Medical Latest Developments
Table 142. Wellead Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 143. Wellead Medical Blood Purification Therapy Product Portfolios and Specifications
Table 144. Wellead Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Wellead Medical Main Business
Table 146. Wellead Medical Latest Developments
Table 147. Shinva Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 148. Shinva Blood Purification Therapy Product Portfolios and Specifications
Table 149. Shinva Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Shinva Main Business
Table 151. Shinva Latest Developments
Table 152. Chengdu Wesley Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 153. Chengdu Wesley Blood Purification Therapy Product Portfolios and Specifications
Table 154. Chengdu Wesley Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Chengdu Wesley Main Business
Table 156. Chengdu Wesley Latest Developments
Table 157. Tuoren Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 158. Tuoren Medical Blood Purification Therapy Product Portfolios and Specifications
Table 159. Tuoren Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Tuoren Medical Main Business
Table 161. Tuoren Medical Latest Developments
Table 162. Jiangxi Hongda Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 163. Jiangxi Hongda Blood Purification Therapy Product Portfolios and Specifications
Table 164. Jiangxi Hongda Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Jiangxi Hongda Main Business
Table 166. Jiangxi Hongda Latest Developments
Table 167. Guanhuai Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 168. Guanhuai Medical Blood Purification Therapy Product Portfolios and Specifications
Table 169. Guanhuai Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Guanhuai Medical Main Business
Table 171. Guanhuai Medical Latest Developments
Table 172. Guangzhou Jihua Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 173. Guangzhou Jihua Blood Purification Therapy Product Portfolios and Specifications
Table 174. Guangzhou Jihua Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 175. Guangzhou Jihua Main Business
Table 176. Guangzhou Jihua Latest Developments
Table 177. Kangbei Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 178. Kangbei Medical Blood Purification Therapy Product Portfolios and Specifications
Table 179. Kangbei Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 180. Kangbei Medical Main Business
Table 181. Kangbei Medical Latest Developments
Table 182. Foshan Biosun Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 183. Foshan Biosun Medical Blood Purification Therapy Product Portfolios and Specifications
Table 184. Foshan Biosun Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 185. Foshan Biosun Medical Main Business
Table 186. Foshan Biosun Medical Latest Developments
Table 187. Fresenius Medical Care Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 188. Fresenius Medical Care Blood Purification Therapy Product Portfolios and Specifications
Table 189. Fresenius Medical Care Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 190. Fresenius Medical Care Main Business
Table 191. Fresenius Medical Care Latest Developments
Table 192. Nikkiso Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 193. Nikkiso Blood Purification Therapy Product Portfolios and Specifications
Table 194. Nikkiso Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 195. Nikkiso Main Business
Table 196. Nikkiso Latest Developments
Table 197. B. Braun Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 198. B. Braun Blood Purification Therapy Product Portfolios and Specifications
Table 199. B. Braun Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 200. B. Braun Main Business
Table 201. B. Braun Latest Developments
Table 202. Vantive Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 203. Vantive Blood Purification Therapy Product Portfolios and Specifications
Table 204. Vantive Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 205. Vantive Main Business
Table 206. Vantive Latest Developments
Table 207. Asahi Kasei Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 208. Asahi Kasei Medical Blood Purification Therapy Product Portfolios and Specifications
Table 209. Asahi Kasei Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 210. Asahi Kasei Medical Main Business
Table 211. Asahi Kasei Medical Latest Developments
Table 212. Nipro Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 213. Nipro Blood Purification Therapy Product Portfolios and Specifications
Table 214. Nipro Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 215. Nipro Main Business
Table 216. Nipro Latest Developments
Table 217. Toray Medical Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 218. Toray Medical Blood Purification Therapy Product Portfolios and Specifications
Table 219. Toray Medical Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 220. Toray Medical Main Business
Table 221. Toray Medical Latest Developments
Table 222. Kaneka Medix Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 223. Kaneka Medix Blood Purification Therapy Product Portfolios and Specifications
Table 224. Kaneka Medix Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 225. Kaneka Medix Main Business
Table 226. Kaneka Medix Latest Developments
Table 227. CytoSorbents Basic Information, Blood Purification Therapy Manufacturing Base, Sales Area and Its Competitors
Table 228. CytoSorbents Blood Purification Therapy Product Portfolios and Specifications
Table 229. CytoSorbents Blood Purification Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 230. CytoSorbents Main Business
Table 231. CytoSorbents Latest Developments
LIST OF FIGURES
Figure 1. Picture of Blood Purification Therapy
Figure 2. Blood Purification Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood Purification Therapy Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Blood Purification Therapy Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Blood Purification Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Blood Purification Therapy Sales Market Share by Country/Region (2025)
Figure 10. Blood Purification Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Hemodialysis
Figure 12. Product Picture of Hemoperfusion
Figure 13. Product Picture of Hemofiltration
Figure 14. Product Picture of Continuous Renal Replacement Therapy
Figure 15. Product Picture of Plasma Exchange And Plasma Adsorption
Figure 16. Product Picture of Other
Figure 17. Global Blood Purification Therapy Sales Market Share by Type in 2026
Figure 18. Global Blood Purification Therapy Revenue Market Share by Type (2021-2026)
Figure 19. Product Picture of Blood Purification Equipment
Figure 20. Product Picture of Blood Purification Consumables
Figure 21. Global Blood Purification Therapy Sales Market Share by Product Form in 2026
Figure 22. Global Blood Purification Therapy Revenue Market Share by Product Form (2021-2026)
Figure 23. Product Picture of Hospitals
Figure 24. Product Picture of Blood Purification Centers
Figure 25. Product Picture of Home Care
Figure 26. Product Picture of Other
Figure 27. Global Blood Purification Therapy Sales Market Share by Care Setting in 2026
Figure 28. Global Blood Purification Therapy Revenue Market Share by Care Setting (2021-2026)
Figure 29. Blood Purification Therapy Consumed in End-Stage Kidney Disease Requiring Long-Term Renal Replacement Therapy
Figure 30. Global Blood Purification Therapy Market: End-Stage Kidney Disease Requiring Long-Term Renal Replacement Therapy (2021-2026) & (K Units)
Figure 31. Blood Purification Therapy Consumed in Acute Kidney Injury And Critical Care Blood Purification
Figure 32. Global Blood Purification Therapy Market: Acute Kidney Injury And Critical Care Blood Purification (2021-2026) & (K Units)
Figure 33. Blood Purification Therapy Consumed in Liver Failure And Artificial Liver Support
Figure 34. Global Blood Purification Therapy Market: Liver Failure And Artificial Liver Support (2021-2026) & (K Units)
Figure 35. Blood Purification Therapy Consumed in Poisoning Blood Purification
Figure 36. Global Blood Purification Therapy Market: Poisoning Blood Purification (2021-2026) & (K Units)
Figure 37. Blood Purification Therapy Consumed in Immune-Mediated Disease Blood Purification
Figure 38. Global Blood Purification Therapy Market: Immune-Mediated Disease Blood Purification (2021-2026) & (K Units)
Figure 39. Blood Purification Therapy Consumed in Metabolic Diseases and Special Component Removal
Figure 40. Global Blood Purification Therapy Market: Metabolic Diseases and Special Component Removal (2021-2026) & (K Units)
Figure 41. Blood Purification Therapy Consumed in Other
Figure 42. Global Blood Purification Therapy Market: Other (2021-2026) & (K Units)
Figure 43. Global Blood Purification Therapy Sale Market Share by Application (2025)
Figure 44. Global Blood Purification Therapy Revenue Market Share by Application in 2025
Figure 45. Blood Purification Therapy Sales by Company in 2025 (K Units)
Figure 46. Global Blood Purification Therapy Sales Market Share by Company in 2025
Figure 47. Blood Purification Therapy Revenue by Company in 2025 ($ millions)
Figure 48. Global Blood Purification Therapy Revenue Market Share by Company in 2025
Figure 49. Global Blood Purification Therapy Sales Market Share by Geographic Region (2021-2026)
Figure 50. Global Blood Purification Therapy Revenue Market Share by Geographic Region in 2025
Figure 51. Americas Blood Purification Therapy Sales 2021-2026 (K Units)
Figure 52. Americas Blood Purification Therapy Revenue 2021-2026 ($ millions)
Figure 53. APAC Blood Purification Therapy Sales 2021-2026 (K Units)
Figure 54. APAC Blood Purification Therapy Revenue 2021-2026 ($ millions)
Figure 55. Europe Blood Purification Therapy Sales 2021-2026 (K Units)
Figure 56. Europe Blood Purification Therapy Revenue 2021-2026 ($ millions)
Figure 57. Middle East & Africa Blood Purification Therapy Sales 2021-2026 (K Units)
Figure 58. Middle East & Africa Blood Purification Therapy Revenue 2021-2026 ($ millions)
Figure 59. Americas Blood Purification Therapy Sales Market Share by Country in 2025
Figure 60. Americas Blood Purification Therapy Revenue Market Share by Country (2021-2026)
Figure 61. Americas Blood Purification Therapy Sales Market Share by Type (2021-2026)
Figure 62. Americas Blood Purification Therapy Sales Market Share by Application (2021-2026)
Figure 63. United States Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 64. Canada Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 65. Mexico Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 66. Brazil Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 67. APAC Blood Purification Therapy Sales Market Share by Region in 2025
Figure 68. APAC Blood Purification Therapy Revenue Market Share by Region (2021-2026)
Figure 69. APAC Blood Purification Therapy Sales Market Share by Type (2021-2026)
Figure 70. APAC Blood Purification Therapy Sales Market Share by Application (2021-2026)
Figure 71. China Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 72. Japan Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 73. South Korea Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 74. Southeast Asia Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 75. India Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 76. Australia Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 77. China Taiwan Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 78. Europe Blood Purification Therapy Sales Market Share by Country in 2025
Figure 79. Europe Blood Purification Therapy Revenue Market Share by Country (2021-2026)
Figure 80. Europe Blood Purification Therapy Sales Market Share by Type (2021-2026)
Figure 81. Europe Blood Purification Therapy Sales Market Share by Application (2021-2026)
Figure 82. Germany Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 83. France Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 84. UK Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 85. Italy Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 86. Russia Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 87. Middle East & Africa Blood Purification Therapy Sales Market Share by Country (2021-2026)
Figure 88. Middle East & Africa Blood Purification Therapy Sales Market Share by Type (2021-2026)
Figure 89. Middle East & Africa Blood Purification Therapy Sales Market Share by Application (2021-2026)
Figure 90. Egypt Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 91. South Africa Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 92. Israel Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 93. Turkey Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 94. GCC Countries Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 95. Manufacturing Cost Structure Analysis of Blood Purification Therapy in 2026
Figure 96. Manufacturing Process Analysis of Blood Purification Therapy
Figure 97. Industry Chain Structure of Blood Purification Therapy
Figure 98. Channels of Distribution
Figure 99. Global Blood Purification Therapy Sales Market Forecast by Region (2027-2032)
Figure 100. Global Blood Purification Therapy Revenue Market Share Forecast by Region (2027-2032)
Figure 101. Global Blood Purification Therapy Sales Market Share Forecast by Type (2027-2032)
Figure 102. Global Blood Purification Therapy Revenue Market Share Forecast by Type (2027-2032)
Figure 103. Global Blood Purification Therapy Sales Market Share Forecast by Application (2027-2032)
Figure 104. Global Blood Purification Therapy Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Blood Purification Therapy
Figure 2. Blood Purification Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood Purification Therapy Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Blood Purification Therapy Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Blood Purification Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Blood Purification Therapy Sales Market Share by Country/Region (2025)
Figure 10. Blood Purification Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Hemodialysis
Figure 12. Product Picture of Hemoperfusion
Figure 13. Product Picture of Hemofiltration
Figure 14. Product Picture of Continuous Renal Replacement Therapy
Figure 15. Product Picture of Plasma Exchange And Plasma Adsorption
Figure 16. Product Picture of Other
Figure 17. Global Blood Purification Therapy Sales Market Share by Type in 2026
Figure 18. Global Blood Purification Therapy Revenue Market Share by Type (2021-2026)
Figure 19. Product Picture of Blood Purification Equipment
Figure 20. Product Picture of Blood Purification Consumables
Figure 21. Global Blood Purification Therapy Sales Market Share by Product Form in 2026
Figure 22. Global Blood Purification Therapy Revenue Market Share by Product Form (2021-2026)
Figure 23. Product Picture of Hospitals
Figure 24. Product Picture of Blood Purification Centers
Figure 25. Product Picture of Home Care
Figure 26. Product Picture of Other
Figure 27. Global Blood Purification Therapy Sales Market Share by Care Setting in 2026
Figure 28. Global Blood Purification Therapy Revenue Market Share by Care Setting (2021-2026)
Figure 29. Blood Purification Therapy Consumed in End-Stage Kidney Disease Requiring Long-Term Renal Replacement Therapy
Figure 30. Global Blood Purification Therapy Market: End-Stage Kidney Disease Requiring Long-Term Renal Replacement Therapy (2021-2026) & (K Units)
Figure 31. Blood Purification Therapy Consumed in Acute Kidney Injury And Critical Care Blood Purification
Figure 32. Global Blood Purification Therapy Market: Acute Kidney Injury And Critical Care Blood Purification (2021-2026) & (K Units)
Figure 33. Blood Purification Therapy Consumed in Liver Failure And Artificial Liver Support
Figure 34. Global Blood Purification Therapy Market: Liver Failure And Artificial Liver Support (2021-2026) & (K Units)
Figure 35. Blood Purification Therapy Consumed in Poisoning Blood Purification
Figure 36. Global Blood Purification Therapy Market: Poisoning Blood Purification (2021-2026) & (K Units)
Figure 37. Blood Purification Therapy Consumed in Immune-Mediated Disease Blood Purification
Figure 38. Global Blood Purification Therapy Market: Immune-Mediated Disease Blood Purification (2021-2026) & (K Units)
Figure 39. Blood Purification Therapy Consumed in Metabolic Diseases and Special Component Removal
Figure 40. Global Blood Purification Therapy Market: Metabolic Diseases and Special Component Removal (2021-2026) & (K Units)
Figure 41. Blood Purification Therapy Consumed in Other
Figure 42. Global Blood Purification Therapy Market: Other (2021-2026) & (K Units)
Figure 43. Global Blood Purification Therapy Sale Market Share by Application (2025)
Figure 44. Global Blood Purification Therapy Revenue Market Share by Application in 2025
Figure 45. Blood Purification Therapy Sales by Company in 2025 (K Units)
Figure 46. Global Blood Purification Therapy Sales Market Share by Company in 2025
Figure 47. Blood Purification Therapy Revenue by Company in 2025 ($ millions)
Figure 48. Global Blood Purification Therapy Revenue Market Share by Company in 2025
Figure 49. Global Blood Purification Therapy Sales Market Share by Geographic Region (2021-2026)
Figure 50. Global Blood Purification Therapy Revenue Market Share by Geographic Region in 2025
Figure 51. Americas Blood Purification Therapy Sales 2021-2026 (K Units)
Figure 52. Americas Blood Purification Therapy Revenue 2021-2026 ($ millions)
Figure 53. APAC Blood Purification Therapy Sales 2021-2026 (K Units)
Figure 54. APAC Blood Purification Therapy Revenue 2021-2026 ($ millions)
Figure 55. Europe Blood Purification Therapy Sales 2021-2026 (K Units)
Figure 56. Europe Blood Purification Therapy Revenue 2021-2026 ($ millions)
Figure 57. Middle East & Africa Blood Purification Therapy Sales 2021-2026 (K Units)
Figure 58. Middle East & Africa Blood Purification Therapy Revenue 2021-2026 ($ millions)
Figure 59. Americas Blood Purification Therapy Sales Market Share by Country in 2025
Figure 60. Americas Blood Purification Therapy Revenue Market Share by Country (2021-2026)
Figure 61. Americas Blood Purification Therapy Sales Market Share by Type (2021-2026)
Figure 62. Americas Blood Purification Therapy Sales Market Share by Application (2021-2026)
Figure 63. United States Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 64. Canada Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 65. Mexico Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 66. Brazil Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 67. APAC Blood Purification Therapy Sales Market Share by Region in 2025
Figure 68. APAC Blood Purification Therapy Revenue Market Share by Region (2021-2026)
Figure 69. APAC Blood Purification Therapy Sales Market Share by Type (2021-2026)
Figure 70. APAC Blood Purification Therapy Sales Market Share by Application (2021-2026)
Figure 71. China Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 72. Japan Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 73. South Korea Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 74. Southeast Asia Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 75. India Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 76. Australia Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 77. China Taiwan Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 78. Europe Blood Purification Therapy Sales Market Share by Country in 2025
Figure 79. Europe Blood Purification Therapy Revenue Market Share by Country (2021-2026)
Figure 80. Europe Blood Purification Therapy Sales Market Share by Type (2021-2026)
Figure 81. Europe Blood Purification Therapy Sales Market Share by Application (2021-2026)
Figure 82. Germany Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 83. France Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 84. UK Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 85. Italy Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 86. Russia Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 87. Middle East & Africa Blood Purification Therapy Sales Market Share by Country (2021-2026)
Figure 88. Middle East & Africa Blood Purification Therapy Sales Market Share by Type (2021-2026)
Figure 89. Middle East & Africa Blood Purification Therapy Sales Market Share by Application (2021-2026)
Figure 90. Egypt Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 91. South Africa Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 92. Israel Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 93. Turkey Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 94. GCC Countries Blood Purification Therapy Revenue Growth 2021-2026 ($ millions)
Figure 95. Manufacturing Cost Structure Analysis of Blood Purification Therapy in 2026
Figure 96. Manufacturing Process Analysis of Blood Purification Therapy
Figure 97. Industry Chain Structure of Blood Purification Therapy
Figure 98. Channels of Distribution
Figure 99. Global Blood Purification Therapy Sales Market Forecast by Region (2027-2032)
Figure 100. Global Blood Purification Therapy Revenue Market Share Forecast by Region (2027-2032)
Figure 101. Global Blood Purification Therapy Sales Market Share Forecast by Type (2027-2032)
Figure 102. Global Blood Purification Therapy Revenue Market Share Forecast by Type (2027-2032)
Figure 103. Global Blood Purification Therapy Sales Market Share Forecast by Application (2027-2032)
Figure 104. Global Blood Purification Therapy Revenue Market Share Forecast by Application (2027-2032)
